GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » OncoTherapy Science Inc (TSE:4564) » Definitions » Shiller PE Ratio

OncoTherapy Science (TSE:4564) Shiller PE Ratio : (As of May. 06, 2025)


View and export this data going back to 2003. Start your Free Trial

What is OncoTherapy Science Shiller PE Ratio?

Shiller PE for Stocks: The True Measure of Stock Valuation


OncoTherapy Science Shiller PE Ratio Historical Data

The historical data trend for OncoTherapy Science's Shiller PE Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

OncoTherapy Science Shiller PE Ratio Chart

OncoTherapy Science Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Shiller PE Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

OncoTherapy Science Quarterly Data
Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Sep24
Shiller PE Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of OncoTherapy Science's Shiller PE Ratio

For the Biotechnology subindustry, OncoTherapy Science's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


OncoTherapy Science's Shiller PE Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, OncoTherapy Science's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where OncoTherapy Science's Shiller PE Ratio falls into.


;
;

OncoTherapy Science Shiller PE Ratio Calculation

For Shiller PE Ratio, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller PE Ratio is also called PE10.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

OncoTherapy Science's E10 for the quarter that ended in Sep. 2024 is calculated as:

For example, OncoTherapy Science's adjusted earnings per share data for the three months ended in Sep. 2024 was:

Adj_EPS=Earnings per Share (Diluted)/CPI of Sep. 2024 (Change)*Current CPI (Sep. 2024)
=0/108.9000*108.9000
=0.000

Current CPI (Sep. 2024) = 108.9000.

OncoTherapy Science Quarterly Data

Earnings per Share (Diluted) CPI Adj_EPS
201409 -3.950 98.500 -4.367
201412 1.680 97.900 1.869
201503 -2.320 97.900 -2.581
201506 -3.670 98.400 -4.062
201509 -5.410 98.500 -5.981
201512 -5.371 98.100 -5.962
201603 -4.523 97.900 -5.031
201606 -5.200 98.100 -5.772
201609 -4.982 98.000 -5.536
201612 -4.780 98.400 -5.290
201703 -5.462 98.100 -6.063
201706 -3.860 98.500 -4.268
201709 -5.440 98.800 -5.996
201712 -5.302 99.400 -5.809
201803 -4.790 99.200 -5.258
201806 -4.400 99.200 -4.830
201809 -6.090 99.900 -6.639
201812 -2.400 99.700 -2.621
201903 -7.010 99.700 -7.657
201906 -4.180 99.800 -4.561
201909 -3.830 100.100 -4.167
201912 -3.150 100.500 -3.413
202003 -2.624 100.300 -2.849
202006 -1.810 99.900 -1.973
202009 -2.482 99.900 -2.706
202012 -2.420 99.300 -2.654
202103 -2.150 99.900 -2.344
202106 -3.000 99.500 -3.283
202109 -3.740 100.100 -4.069
202112 -4.780 100.100 -5.200
202203 -2.244 101.100 -2.417
202206 -1.440 101.800 -1.540
202209 -1.750 103.100 -1.848
202212 -1.554 104.100 -1.626
202303 -1.070 104.400 -1.116
202306 -1.990 105.200 -2.060
202309 -1.430 106.200 -1.466
202312 -1.271 106.800 -1.296
202403 -1.382 107.200 -1.404
202409 0.000 108.900 0.000

Add all the adjusted EPS together and divide 10 will get our E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


OncoTherapy Science  (TSE:4564) Shiller PE Ratio Explanation

Compared with the regular PE Ratio, which works poorly for cyclical businesses, the Shiller PE Ratio smoothed out the fluctuations of profit margins during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Shiller PE Ratio should give similar results to regular PE Ratio.

Compared with the PS Ratio, the Shiller PE Ratio makes the comparison between different industries more meaningful.


Be Aware

Shiller PE Ratio assumes that over the long term, businesses and profitability revert to their means. If a company's business model does not work in the future compared with the past, Shiller PE Ratio and PS Ratio will give false valuations.


OncoTherapy Science Shiller PE Ratio Related Terms

Thank you for viewing the detailed overview of OncoTherapy Science's Shiller PE Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


OncoTherapy Science Business Description

Traded in Other Exchanges
N/A
Address
11th Floor, Kanagawa Science Park R&D, 3-2-1 Sakado, Kanagawa, Kawasaki, JPN, 213-0012
OncoTherapy Science Inc focuses on cancer-related cells and genes and develops cancer therapy products which include low molecular drugs, antibody drugs, cancer peptide vaccine, and diagnostic medicine in Japan.

OncoTherapy Science Headlines

No Headlines